NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-158-2000-0-EP-04 Novel Chimeric Rev, TAT and NEF Antigens EP National Stage 02805519.2 Abandoned
NHLBI E-035-2003-0-US-01 Variable Curve Catheter US 60/426,542 Abandoned
NHLBI E-010-2003-0-US-01 Method And Devices For Image-Guided Catheter-based Percutaneous Repair Of Regurgitant Cardiac Valves US 60/426,984 Abandoned
NHLBI E-037-2003-0-US-01 Method for the Diagnosis and Treatment of Vascular Disease US 60/426,545 Abandoned
NIAID E-051-2002-0-CA-02 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation CA National Stage 2470104 Expired
NIAID E-051-2002-0-NL-16 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation NL EP 02804693.6 Expired
NIAID E-051-2002-0-ES-11 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation ES EP 02804693.6 Expired
NIAID E-051-2002-0-CH-09 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation CH EP 02804693.6 Expired
NIAID E-051-2002-0-GB-13 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation GB EP 02804693.6 Expired
NIAID E-051-2002-0-DK-17 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation DK EP 02804693.6 Expired
NIAID E-051-2002-0-DE-10 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation DE EP 02804693.6 Expired
NIAID E-051-2002-0-FR-12 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation FR EP 02804693.6 Expired
NIAID E-051-2002-0-IT-15 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation IT EP 02804693.6 Expired
NIAID E-051-2002-0-IE-14 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation IE EP 02804693.6 Expired
NIAID E-051-2002-0-EP-03 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation EP National Stage 02804693.6 Expired
NIAID E-051-2002-0-AU-05 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation AU National Stage 2002356962 Expired
NIAID E-051-2002-0-PCT-01 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation PCT PCT COMB PCT/US2002/036829 Expired
NIAID E-051-2002-0-JP-04 Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation JP National Stage 2003-551263 Abandoned
NICHD E-043-2003-0-US-01 Biomarkers for Intra-Amniotic Inflammation US 60/426,096 Abandoned
NCI E-005-2002-0-EP-04 Gene Expressed in Prostate Cancer and Methods of Use EP National Stage 02795643.2 Abandoned
NCI E-005-2002-0-PCT-02 Discovery of New Gene Expressed in Prostate Cancer PCT PCT PCT/US02/36648 Expired
NIAID E-052-2004-0-US-02 Synthetic Genes For Malarial Proteins and Methods of Use US ORD 10/293,913 7078507 Expired PDF
NIAID E-052-2004-0-PCT-03 Synthetic Genes For Malarial Proteins and Methods Of Use PCT PCT PCT/US02/036368 Expired
NCI E-219-2002-0-US-01 Novel use of T22 Peptide to Block CXCR4-Mediated Cancer Metastasis US 60/425,472 Abandoned
NIAID E-072-2003-0-US-01 P. Ariasi Polypeptides And P. Perniciosus Polypeptides Methods Of Use US 60/425,852 Abandoned
NICHD E-191-2001-0-US-01 GP-64 Pseudotyped Vectors and Uses Thereof US 60/425,853 Abandoned
NCI E-075-2000-0-JP-05 NITRIC OXIDE Releasing Metallic Medical Devices JP National Stage 2001-581880 Expired
NICHD E-023-2002-0-US-02 Methods for Preparing Bacillus Anthracis Protective Antigen For Use In Vaccines US ORD 10/290,712 7763451 Expired PDF
NHLBI E-325-2001-2-CA-03 Production of Adeno-Associated Virus in Insect Cells CA National Stage 2467959 Expired
NHLBI E-325-2001-2-EP-04 Production of Adeno-Associated Virus in Insect Cells EP National Stage 02795604.4 Expired
NHLBI E-325-2001-2-AU-05 Production of Adeno-Associated Virus in Insect Cells AU National Stage 2002360355 Expired
NHLBI E-325-2001-2-PCT-01 Production of Adeno-Associated Virus in Insect Cells PCT PCT COMB PCT/US2002/035829 Expired
NIAID E-278-2001-0-PCT-02 Hepatitis E Virus Clones and Methods of Their Use PCT PCT PCT/US02/36096 Expired
NIDCR E-308-2003-2-US-01 EUKARYOTIC TRANSLATION INITIATION FACTOR 5A (eIF-5A) and THEIR USE TO CONTROL PROLIFERATION OF CELLS US 60/424,978 Abandoned
NIAID E-356-2001-0-PCT-02 Anti-Hepatitis A Virus Antibodies PCT PCT PCT/US2002/036077 Expired
NCI E-294-2002-0-US-01 A New Target for Angiogenesis and Anti-angiogenesis Therapy US 60/425,018 Abandoned
NCI E-209-2002-0-US-01 Method for Separating Recombinant Immunotoxin US 60/425,170 Abandoned
NCI E-249-2002-0-US-01 Smallpox Vaccine Regimen US 60/425,148 Abandoned
NCI E-339-2001-0-US-02 Filtration of Red Blood Cells US ORD 10/289,686 Abandoned
NHLBI E-320-2002-0-US-01 Detection of Mutational Frequency in Human Bone Marrow By Sequencing of Mitochondrial DNA From Single Cells US 60/424,515 Abandoned
NCI E-195-2001-2-PCT-02 Chemoprotectant Compositions PCT PCT PCT/US2002/035437 Expired
NIAID E-250-2002-0-US-01 Safer Attentuated Virus Vaccines with Missing or Diminished Latency of Infection US 60/423,603 Abandoned
NCI E-248-2002-0-US-01 "Methods and Composition for the Diagnosis of Neuroendocrine Lung Cancer" US 60/423,380 Abandoned
NCI E-011-2002-0-US-02 Semaphorin 3 B(SEMA3B) as Diagnostic And Therapeutic Agent For Human Cancer US CON 10/285,351 7781413 Abandoned PDF
NCI E-360-2001-0-PCT-02 Generation And Use of Tc1 And Tc2 Cells PCT PCT PCT/US02/35240 Expired
NCI E-233-2002-0-US-01 Method of Distinguishing Epithelioid Melanaoma From Fibroblastoid Melanoma US 60/422,733 Abandoned
NCI E-232-2002-0-US-01 9-10InsC in 5'UTR May Be Useful Polymorphism in Identification of Melanoma Metastasis US 60/422,821 Abandoned
NCI E-044-1991-2-US-02 TRUNCATED HEPATOCYTE GROWTH FACTOR VARIANTS US DIV 10/283,769 7605127 Expired PDF
NCI E-025-2003-0-US-01 Methods for Prophylaxis and Treatment of HER-2/neu Tumors US 60/422,395 Abandoned
NIAID E-240-2002-0-US-01 HTLV-1-Cell Binding & Inhibition US 60/422,803 Abandoned